🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cervical Esophagus Adenocarcinoma

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma NCT00288119n/a10 sites📍 Baltimore📍 Rochester📍 St Louis Case Western Reserve University · Tests: Balloon Capsule Device, Endoscopy A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project. NCT06803147n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Discontinued endoscopic surveillance Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery NCT07159711n/a4 sites📍 Guildford📍 London📍 London Guy's and St Thomas' NHS Foundation Trust · Tests: Seismofit A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma NCT07818018Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intratumoral 2141-V11, Nivolumab, Fluoropyrimidine Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma NCT07222657Phase 21 site📍 Weston Case Comprehensive Cancer Center · Tests: Standard of care chemotherapy, LNSC NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer NCT04615013Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Capecitabine, Carboplatin, Docetaxel, Fluorouracil, Hafnium Oxide-containing Nanoparticles NBTXR3 Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction NCT06161818Phase 210 sites📍 Eindhoven📍 Leeuwarden📍 Tilburg Erasmus Medical Center · Tests: FLOT-CROSS or CROSS-FLOT Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) NCT06469944Phase 1, Phase 250 sites📍 Tucson📍 Los Angeles📍 Louisville Merck Sharp & Dohme LLC · Tests: Pembrolizumab, Sacituzumab Tirumotecan (sac-TMT), Capecitabine, Leucovorin, Levoleucovorin Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy NCT06687876Phase 22 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Metformin A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer NCT06523374NA9 sites📍 Edegem📍 Wilrijk📍 Ghent University Hospital, Antwerp · Tests: Endoscopic brush cytology A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors NCT06657144Phase 130 sites📍 Tucson📍 Duarte📍 Aurora Coherus Oncology, Inc. · Tests: CHS-114, Toripalimab, 5 Fluorouracil, Cisplatin Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer? NCT07375420NA1 site📍 Guildford University of Surrey · Tests: Low intensity exercise, High intensity exercise InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples EMR Versus ESD for Barrett's Neoplasia NCT05276791NA6 sites📍 Amsterdam📍 Eindhoven📍 Groningen St. Antonius Hospital · Tests: EMR, ESD A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites📍 Anchorage📍 Fayetteville📍 Rogers Seagen, a wholly owned subsidiary of Pfizer · Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy NCT07309991n/a6 sites📍 Guangzhou📍 Shantou📍 Shijiazhuang Sun Yat-sen University A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors NCT07182149Phase 118 sites📍 Denver📍 New Haven📍 Washington D.C. Normunity AccelCo, Inc. · Tests: NRM-823 Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 NCT07431281Phase 3314 sites📍 Birmingham📍 Mobile📍 Anchorage AstraZeneca · Tests: Sonesitatug vedotin, Rilvegostomig, Nivolumab, Capecitabine, 5-Fluorouracil Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA NCT07070466Phase 22 sites📍 Santa Monica📍 Boston Massachusetts General Hospital · Tests: Ivonescimab, 5-Fluorouracil, Oxaliplatin, Leucovorin Patient Preference for Subcutaneous vs. Intravenous Immune Therapy NCT07223424Phase 21 site📍 Pittsburgh Diwakar Davar · Tests: nivolumab, pembrolizumab Registry for Esophageal and Gastroesophageal Junction Cancer NCT06558786n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: EORTC QLQ-C30 questionnaire, QLQ-OGS25 questionnaire SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer NCT05188313Phase 31 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Trastuzumab, Pertuzumab, Paclitaxel, Carboplatin Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site📍 Multiple Locations iOMEDICO AG · Tests: Routine care as per site standard Breath Research Narrow Validation for Gastrointestinal Cancer Detection NCT07714538n/a6 sites📍 Maidstone📍 Liverpool📍 Glasgow Imperial College London First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors NCT07284186Phase 110 sites📍 Scottsdale📍 Duarte📍 Orange Plexium, Inc. · Tests: PLX-61639 Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer NCT03161522Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Capecitabine, Chemotherapy, Conventional Surgery, Fluorouracil, Radiation Therapy Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy